Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Aesculap Biologics, LLC
This study is an extension of protocol AAG-G-H-1220 wherein patients were randomized to either NOVOCART 3D or Microfracture treatment groups. This prospective single arm extension study is only open to participants of AAG-G-H-1220 who were randomized to Microfracture treatment and who failed Microfracture treatment.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
participated in study AAG-G-H-1220
identified as a microfracture failure patient
voluntary consent to participate in the study
You may not be if
other cartilage repair procedures performed on target knee
other conditions that would interfere with healing or evaluating outcomes
lesions requiring implants larger than 9cm2
non-compliance with requirements in study AAG-G-H-1220